Researchers in the WashU Medicine Department of Ophthalmology & Visual Sciences have discovered key neuroprotective genes that could lead to the development of gene therapies to treat retinitis pigmentosa, an inherited form of retinal degeneration that causes blindness. The findings, published in Neuron, point to new therapeutic strategies to maintain retinal health and protect against degeneration.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

100-fold improvement in sight seen after gene therapy trial

Credit: Unsplash/CC0 Public Domain The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after

How a membrane lipid tunes the eye’s response to light

PIP2 binds to rod CNG channels and prevents cGMP-dependent channel opening, increasing rod sensitivity to dim light. Cations (blue), cGMP (light blue), and PIP2 (orange) are represented as spheres. See

Retinal damage after the 2024 solar eclipse

Credit: Unsplash/CC0 Public Domain On April 8, 2024, a once-in-a-lifetime total solar eclipse kept the eyes of millions of Quebecers riveted on the sky. But the experience left at least